artemether has been researched along with Parasitemia in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (11.11) | 18.2507 |
| 2000's | 17 (31.48) | 29.6817 |
| 2010's | 18 (33.33) | 24.3611 |
| 2020's | 13 (24.07) | 2.80 |
| Authors | Studies |
|---|---|
| Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM | 1 |
| Abuom, D; Akala, HM; Andagalu, B; Chemwor, G; Cheruiyot, A; Cowden, J; Juma, D; Kamau, E; Ogutu, B; Okoth, R; Okudo, C; Onyango, I; Opot, B; Sifuna, P; Wafubwa, J; Watson, OJ; Yalwala, S; Yeda, R | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jaiteh, FK; Oboh, M; Oriero, E; Tadele, G | 1 |
| Barnes, KI; Berghmans, PJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Escoffier, E; Flynn, J; Gobeau, N; Izquierdo-Juncàs, D; Jansen, B; Kümmel, A; Marx, MW; Mitov, V; Möhrle, JJ; Rosanas-Urgell, A; Van Geertruyden, JP; Van Leuven, K | 1 |
| Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME | 1 |
| Falade, CO; Funwei, RI; Hammed, WA; Ojurongbe, O; Uyaiabasi, GN; Walker, O | 1 |
| Abd-Rahman, AN; Barber, BE; Birrell, GW; Edstein, MD; Leelasena, I; Llewellyn, S; Marquart, L; McCarthy, JS; Moehrle, JJ; Potter, AJ; Sahai, N; Shanks, GD; Webster, R; Wesche, D | 1 |
| Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P | 1 |
| Aygen, B; Kalın Ünüvar, G; Türe, Z; Yaman, O; Yıldız, O | 1 |
| Adebanjo, IM; Ademowo, OG; Ajayi, AM | 1 |
| Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Bamadio, A; Barry, N; Beshir, KB; Compaore, YD; Coulibaly, M; Coulibaly, SA; Dama, S; Dao, F; Dara, N; Diallo, N; Diarra, A; Djimde, A; Fofana, B; Kaboré, JM; Kabore, NT; Kodio, A; Maurice, OS; Nikiema, F; Ouédraogo, JB; Sagara, I; Sirima, SB; Sombie, S; Somé, FA; Soulama, I; Sutherland, CJ; Togo, AH; Traore, A; Traore, OB; Zongo, I | 1 |
| Álvarez-Larrotta, C; Aponte, S; Bernal, SD; González, C; Guerra, ÁP; Knudson-Ospina, A; Restrepo, C; Yasnot, MF | 1 |
| Akinyi, S; Alemayehu, BH; Birhanu, SG; Demeke, L; Filler, S; Green, M; Hoos, D; Hwang, J; Jima, D; Kachur, SP; Kassa, M; Malone, JL; Melaku, Z; Nettey, H; Poe, A; Reithinger, R; Tekleyohannes, SG; Udhayakumar, V | 1 |
| Rehman, MU; Shrestha, B; Thapa, S; Zehri, T | 1 |
| Pathak, S; Patil, S; Patravale, V; Sharma, S; Suryavanshi, S | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
| Agubata, CO; Attama, AA; Mueller-Goymann, CC; Nzekwe, IT; Onunkwo, GC | 1 |
| Cabrales, P; Carvalho, LJ; Kuypers, FA; Oronsky, B; Scicinski, J; Yalcin, O | 1 |
| Batra, S; Biswas, S; Chauhan, BS; Gunjan, S; Pandey, SK; Singh, S; Singh, SK; Srivastava, K; Tripathi, R | 1 |
| Arinaitwe, E; Aweeka, FT; Bergqvist, Y; Bigira, V; Blessborn, D; Creek, DJ; Kakuru, A; McCormack, SA; Muhindo, M; Parikh, S; Sambol, NC; Sukumar, N; Tappero, JW; Tchaparian, E; Wanzira, H | 1 |
| Arens, TA; de Mast, Q; Druilhe, P; Hermsen, CC; Luty, AJ; Nieman, AE; Roestenberg, M; Sauerwein, RW; Swinkels, DW; van der Ven, AJ; van Dongen-Lases, EC | 1 |
| de Mast, Q; Druilhe, P; Nieman, AE; Pop, G; Roestenberg, M; Sauerwein, R; Stalenhoef, A; van der Ven, A; Wiersma, J | 1 |
| Cabrales, P; Carvalho, LJ; Frangos, JA; Meays, D; Zanini, GM | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Kopel, E; Marhoom, E; Schwartz, E; Sidi, Y | 1 |
| Bruno, FP; Dai, M; Desruisseaux, MS; Freeman, B; Reznik, SE; Shikani, HJ; Stephani, RA; Tanowitz, HB; Weiss, LM | 1 |
| Joshi, M; Pathak, S; Patil, S; Patravale, V; Sharma, S | 1 |
| Arai, M; Ishii, A; Matsuoka, H | 1 |
| Gamble, C; Garner, P; Omari, AA | 1 |
| Adjuik, M; Afful, TM; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Oduro, AR; Owusu-Agyei, S | 1 |
| Dietz, K; English, M; Marsh, K; Muller, I; Smith, T; Vounatsou, P | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Aceng, JR; Byarugaba, JS; Tumwine, JK | 1 |
| Chan, HW; Gerena, L; Haynes, RK; Ho, WY; Ko, CK; Kyle, DE; Peters, W; Robinson, BL | 1 |
| Arbe-Barnes, S; Brun, R; Kocken, CH; Matile, H; Scheurer, C; Thomas, AW; van der Wel, A; Wittlin, S | 1 |
| Chiswell, GM; Dabod, E; Davis, TM; Hamzah, J; Ilett, KF; Karunajeewa, HA; Lorry, K; Page-Sharp, M; Reeder, J | 1 |
| Chollet, J; Shu-Hua, X; Tanner, M; Utzinger, J | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
| Kano, S; Krudsood, S; Looareesuwan, S; Luplertlop, N; Muangnoicharoen, S; Ringwald, P; Srivilairit, S; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Ilesanmi, AO; Oduola, AM; Salako, LA; Sowunmi, A | 1 |
| Odulola, AM; Sowunmi, A | 1 |
| Breton, G; Le Bras, M; Nicolas, X | 1 |
| Courval, JM; Molyneux, ME; Taylor, TE; Wills, BA | 1 |
| Gravenor, MB; Kwiatkowski, D; van Hensbroek, MB | 1 |
| Bhandari, S; Saxena, GN; Sharma, P; Sharma, UB; Swarup, D; Tuteja, R | 1 |
| Bringmann, G; Chimanuka, B; François, G; Heyden, YV; Holenz, J; Plaizier-Vercammen, J; Timperman, G | 1 |
| Chimanuka, B; Detaevernier, MR; Gabriëls, M; Plaizier-Vercammen, JA | 1 |
3 review(s) available for artemether and Parasitemia
| Article | Year |
|---|---|
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Topics: Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Parasitemia; Randomized Controlled Trials as Topic; Sesquiterpenes; Treatment Outcome | 2004 |
17 trial(s) available for artemether and Parasitemia
| Article | Year |
|---|---|
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Parasitemia; Parasites; Plasmodium falciparum; Sporozoites | 2022 |
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda | 2023 |
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment | 2023 |
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine | 2023 |
In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Ethanolamines; Ethiopia; Female; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Prospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Efficacy of Quinine versus Artemether in the treatment of severe malaria.
Topics: Acute Disease; Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coma; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinine; Treatment Outcome | 2013 |
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
Topics: Antimalarials; Artemether; Artemisinins; Black People; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
A randomized, comparative study of two regimens of beta-artemether for the treatment of uncomplicated, Plasmodium falciparum malaria, in northern Ghana.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Bayes Theorem; Child, Preschool; Humans; Kenya; Longitudinal Studies; Malaria, Falciparum; Markov Chains; Models, Biological; Monte Carlo Method; Parasitemia; Plasmodium falciparum; Quinine; Sesquiterpenes | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial.
Topics: Administration, Rectal; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Humans; Infant; Infusions, Intravenous; Malaria, Cerebral; Parasitemia; Quinine; Sesquiterpenes; Single-Blind Method; Suppositories; Time Factors; Treatment Outcome; Uganda | 2005 |
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Endemic Diseases; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Retrospective Studies; Sesquiterpenes; Severity of Illness Index; Suppositories | 2006 |
Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Topics: Adolescent; Aged; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Thailand; Treatment Outcome | 2007 |
Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Erythrocytes; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Retrospective Studies; Sesquiterpenes | 1996 |
Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Coma; Electrocardiography; Female; Fever; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria, Cerebral; Male; Nervous System Diseases; Parasitemia; Prognosis; Quinine; Recurrence; Sesquiterpenes; Survival Analysis; Time Factors | 1998 |
An open study to evaluate the efficacy of artemether in severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Male; Parasitemia; Pilot Projects; Sesquiterpenes; Treatment Outcome | 1999 |
34 other study(ies) available for artemether and Parasitemia
| Article | Year |
|---|---|
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence | 2022 |
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Humans; Kenya; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Disease Progression; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Sudan; Treatment Outcome | 2022 |
High prevalence of persistent residual parasitemia on days 3 and 14 after artemether-lumefantrine or pyronaridine-artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Nigeria; Parasitemia; Plasmodium falciparum; Prevalence | 2023 |
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Healthy Volunteers; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
[Domestic Malaria Cases in Kayseri Province].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Travel | 2023 |
Vitamin C-rich juice co-administration with artemether-lumefantrine ameliorates oxido-inflammatory responses in Plasmodium berghei-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ascorbic Acid; Interleukin-6; Malaria; Malondialdehyde; Mice; Parasitemia; Plasmodium berghei; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Drug Combinations; Ethanolamines; Humans; Malaria, Falciparum; Mali; Parasitemia; Plasmodium falciparum; Treatment Failure | 2021 |
Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Colombia; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult | 2017 |
Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Disease Models, Animal; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei | 2013 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Drug Carriers; Fats; Malaria; Mice; Parasitemia; Particle Size; Phosphatidylcholines; Plasmodium berghei; Seeds; Solubility | 2015 |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Azetidines; Carboxylic Ester Hydrolases; Disease Models, Animal; Drug Combinations; Glucosephosphate Dehydrogenase; Humans; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Motor Activity; Nitro Compounds; Parasitemia; Plasmodium berghei | 2015 |
Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic study.
Topics: Acridines; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Drug Therapy, Combination; Lethal Dose 50; Malaria, Falciparum; Mice; Parasitemia; Plasmodium falciparum; Pyrrolidines | 2016 |
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection.
Topics: Adult; Antimalarials; Antimicrobial Cationic Peptides; Artemether; Artemisinins; Biomarkers; C-Reactive Protein; Cell Count; Erythrocytes; Ethanolamines; Female; Ferritins; Fluorenes; Hemoglobins; Hepcidins; Homeostasis; Humans; Interleukin-6; Iron; Iron, Dietary; Linear Models; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Reticulocytes; Young Adult | 2009 |
Cardiac complication after experimental human malaria infection: a case report.
Topics: Acute Coronary Syndrome; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Human Experimentation; Humans; Insect Bites and Stings; Lumefantrine; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Treatment Outcome; Vaccination | 2009 |
Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
Topics: Animals; Artemether; Artemisinins; Arterioles; Body Temperature; Cell Adhesion; Cerebrovascular Circulation; Erythrocytes; Leukocytes; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Microcirculation; Nimodipine; Parasitemia; Plasmodium berghei; Survival Analysis; Vasoconstriction; Vasodilation; Vasospasm, Intracranial | 2010 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Retrospective Studies; Treatment Outcome; World Health Organization; Young Adult | 2012 |
The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cerebral Hemorrhage; Drug Synergism; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Endothelin-1; Female; Hydroxyquinolines; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Microvessels; Parasitemia; Plasmodium berghei; Random Allocation; Survival | 2012 |
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Treatment Outcome | 2012 |
Laboratory evaluation of the ict malaria P.f./P.v. immunochromatographic test for detecting the panmalarial antigen using a rodent malaria model.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Chromatography; Disease Models, Animal; False Negative Reactions; False Positive Reactions; Female; Fructose-Bisphosphate Aldolase; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sesquiterpenes | 2004 |
Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Malaria; Mice; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Sesquiterpenes | 2005 |
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
Topics: Animals; Antimalarials; Aotidae; Artemether; Artemisinins; Artesunate; Benzamidines; Chloroquine; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Malaria, Vivax; Parasitemia; Peroxides; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes; Spiro Compounds; Time Factors | 2006 |
Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Humans; Intestines; Liver; Malaria; Mice; Parasitemia; Plasmodium berghei; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Artemether treatment of recrudescent Plasmodium falciparum malaria in children.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Parasitemia; Prospective Studies; Recurrence; Sesquiterpenes; Time Factors | 1997 |
[Use of artemether in the treatment of severe malaria, an alternative in an unusual situation].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Injections, Intramuscular; Malaria, Falciparum; Parasitemia; Sesquiterpenes | 1997 |
Estimating sequestered parasite population dynamics in cerebral malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Erythrocytes; Host-Parasite Interactions; Humans; Malaria, Cerebral; Parasitemia; Plasmodium falciparum; Quinine; Sesquiterpenes | 1998 |
A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Female; Isoquinolines; Life Cycle Stages; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Sesquiterpenes | 2001 |
Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Liposomes; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Secondary Prevention; Sesquiterpenes; Spectrophotometry, Ultraviolet | 2002 |